Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review.
Saved in:
| Title: | Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review. |
|---|---|
| Authors: | Burger CD; Division of Pulmonary Medicine, Mayo Clinic Florida, Jacksonville, FL, USA., Tsang Y; Janssen Scientific Affiars, Titusville, NJ, USA., Chivers M; Avalere Health, Fleet, UK., Vekaria RV; Avalere Health, Fleet, UK., Doad G; Janssen Scientific Affiars, Titusville, NJ, USA.; Actelion Pharmaceuticals US, Inc, A Johnson and Johnson Co., Titusville, NJ, USA., Atkins N; Avalere Health, Fleet, UK., Panjabi S; Janssen Scientific Affiars, Titusville, NJ, USA.; Actelion Pharmaceuticals US, Inc, A Johnson and Johnson Co., Titusville, NJ, USA. |
| Source: | ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2024 May 30; Vol. 16, pp. 447-459. Date of Electronic Publication: 2024 May 30 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
